Zynerba Press Releases

11 Aug 16 Zynerba Pharmaceuticals Reports Second Quarter 2016 Financial Results and Organizational Changes

3 Aug 16 Zynerba Pharmaceuticals to Present at Canaccord Genuity’s 36th Annual Growth Conference

1 Aug 16 Zynerba Pharmaceuticals Announces Dosing of First Patients in Phase 2 STAR 1 Clinical Study of ZYN002 CBD Gel in Adult Epilepsy Patients with Refractory Focal Seizures

6 Jul 16 Zynerba Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

27 Jun 16 Zynerba Pharmaceuticals Announces Positive Top Line Results from ZYN002 CBD Gel Phase 1 Multiple Rising Dose Trial and Initiation of Phase 2 Study in Adult Epilepsy Patients with Refractory Focal Seizures

1 Jun 16 Zynerba Pharmaceuticals to Participate in Upcoming Investor Meetings and Conferences

12 May 16 Zynerba Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Highlights

12 Apr 16 Cannabis and Cannabinoid Research Publishes Data Demonstrating the Degradation of Cannabidiol to Psychoactive Cannabinoids when Exposed to Simulated Gastric Fluid

14 Mar 16 Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results and Operational Highlights

7 Mar 16 Zynerba Pharmaceuticals to Present at 28th Annual ROTH Conference